Cargando…

Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma

BACKGROUND: The role of adjuvant chemotherapy in esophageal squamous cell carcinoma (ESCC) remains controversial. This study aimed to evaluate the impact of adjuvant chemotherapy on survival in patients with positive nodes after surgery for ESCC. METHODS: We retrospectively reviewed the survival out...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeon, Yeong Jeong, Cho, Jong Ho, Choi, Yong Soo, Shim, Young Mog, Sun, Jong‐Mu, Kim, Hong Kwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968597/ https://www.ncbi.nlm.nih.gov/pubmed/36631064 http://dx.doi.org/10.1111/1759-7714.14796

Ejemplares similares

The Role of Adjuvant Chemotherapy after Neoadjuvant Chemoradiotherapy Followed by Surgery in Patients with Esophageal Squamous Cell Carcinoma
por: Park, Seong Yong, et al.
Publicado: (2023)

Adjuvant Chemotherapy in Patients with Node-Negative Non-Small Cell Lung Cancer with Satellite Pulmonary Nodules in the Same Lobe
por: Park, Jiyoun, et al.
Publicado: (2022)

Management of patients with bilateral recurrent laryngeal nerve paralysis following esophagectomy
por: Jeon, Yeong Jeong, et al.
Publicado: (2021)

The Role of Adjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma Patients with Pathological Positive Lymph Nodes After Neoadjuvant Chemotherapy Followed by Esophagectomy: a Single Institute Retrospective Analysis
por: Imai, Takeharu, et al.
Publicado: (2021)

A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma
por: Lim, Sung Hee, et al.
Publicado: (2017)

Adjuvant chemotherapy with paclitaxel and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma
por: Zhang, Liangze, et al.
Publicado: (2017)

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
por: Sun, Jong-Mu
Publicado: (2020)

Surgically resected T1‐ and T2‐stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT
por: Jeong, Dong Young, et al.
Publicado: (2018)

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors
por: Jeong, Dong Young, et al.
Publicado: (2020)

Reflux Following Esophagectomy for Esophageal Cancer
por: Cho, Jong Ho
Publicado: (2020)

Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
por: Cho, Won Kyung, et al.
Publicado: (2016)

Efficacy of adjuvant chemotherapy on overall survival in patients with lymph node‐positive esophageal squamous cell carcinoma: Is oral chemotherapy promising?
por: Fang, Shuogui, et al.
Publicado: (2022)

Prognosis of patients with esophageal squamous cell carcinoma after esophagectomy using the log odds of positive lymph nodes
por: Wu, San-Gang, et al.
Publicado: (2015)

Adjuvant chemotherapy for lymph node positive esophageal squamous cell cancer: The prediction role of low mean platelet volume
por: Liu, Xiaoling, et al.
Publicado: (2022)

Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer
por: Hirahara, Noriyuki, et al.
Publicado: (2022)

Delayed Gastric Emptying after Esophagectomy: Management and Prevention
por: Yang, Hee Chul, et al.
Publicado: (2020)

Postoperative adjuvant chemotherapy versus chemoradiotherapy for node-positive esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Wang, Qifeng, et al.
Publicado: (2020)

Role of intraoperative feeding jejunostomy in esophageal cancer surgery
por: Kim, Min Soo, et al.
Publicado: (2022)

Squamous Cell Carcinoma Arising from the Pleural Cavity After Pneumonectomy for Chronic Empyema
por: Jeon, Yeong Jeong, et al.
Publicado: (2017)

Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial?
por: Zou, Bingwen, et al.
Publicado: (2020)

Adjuvant Therapy for a Microscopically Incomplete Resection Margin after an Esophagectomy for Esophageal Squamous Cell Carcinoma
por: Qiu, Bo, et al.
Publicado: (2017)

Prognosis After Surgical Resection of M1a/M1b Esophageal Squamous Cell Carcinoma
por: Shim, Young Mog, et al.
Publicado: (2005)

Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma
por: Shin, Dong Wook, et al.
Publicado: (2022)

Clinical Trends in Management of Locally Advanced ESCC: Real-World Evidence from a Large Single-Center Cohort Study
por: Jeon, Yeong Jeong, et al.
Publicado: (2022)

Safety and Feasibility of Esophagectomy Following Neoadjuvant Immunotherapy Combined with Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Gu, Yi-Min, et al.
Publicado: (2022)

Effect of Time to Minimally Invasive Esophagectomy After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
por: Loc, Nguyen Vo Vinh, et al.
Publicado: (2023)

The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study
por: He, Hongbo, et al.
Publicado: (2022)

Comparison of Up-Front Minimally Invasive Esophagectomy versus Open Esophagectomy on Quality of Life for Esophageal Squamous Cell Cancer
por: Li, Zhenhua, et al.
Publicado: (2021)

Comparisons of minimally invasive esophagectomy and open esophagectomy in lymph node metastasis/dissection for thoracic esophageal cancer
por: Li, Zhenhua, et al.
Publicado: (2022)

Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma
por: Ma, Shaohua, et al.
Publicado: (2018)

Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer
por: Boone, Judith, et al.
Publicado: (2016)

Management of chyle leakage after general thoracic surgery: Impact of thoracic duct embolization
por: Jeon, Yeong Jeong, et al.
Publicado: (2021)

The Role of Adjuvant Chemotherapy in the Treatment of Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemotherapy
por: Li, Keting, et al.
Publicado: (2023)

Feasibility and strategy of common hepatic artery lymph node dissection in thoracolaparoscopic esophagectomy for thoracic esophageal squamous cell cancer
por: Han, Zi-Yang, et al.
Publicado: (2018)

Diaphragmatic Hernia after Transhiatal Esophagectomy for Esophageal Cancer
por: Kim, Dohun, et al.
Publicado: (2016)

Clinical impact of remnant lymphatic invasion on the recurrence of esophageal squamous cell carcinoma after esophagectomy with neoadjuvant chemotherapy
por: Okuda, Sho, et al.
Publicado: (2022)

Endoscopic resection with adjuvant treatment versus esophagectomy for early-stage esophageal cancer
por: Huang, Binhao, et al.
Publicado: (2021)

Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Chang, Yi-Lin, et al.
Publicado: (2022)

Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
por: Lee, Hyunjong, et al.
Publicado: (2022)

Prognostic impact of lymph node ratio in patients with pT1–2N1M0 non-small cell lung cancer
por: Shin, Sumin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l35igcegdg4unu33ucd5qs5a7k